List view / Grid view
22 December 2015 | By Victoria White
A study suggests that enhancing proteasome activity with drugs during the early stages of Alzheimer’s may prevent dementia and reduce damage to the brain...
16 November 2015 | By Victoria White
Scientists have conducted research to suppress an abnormal assembly of beta-amyloids by using photo-excited porphyrins...
13 November 2015 | By Victoria White
Mice treated with J147 had better memory and cognition, healthier blood vessels in the brain and other improved physiological features...
30 October 2015 | By Victoria White
The discovery about the FUS protein could be a major milestone on the path to a treatment for both motor neurone disease and dementia...
21 October 2015 | By Kate Douetil
This innovative new global investment fund has gained support from a wide variety of investors, including the UK Government’s Department of Health (DoH), Alzheimer’s Research UK and world-leading major pharmaceutical companies Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda...
14 October 2015 | By Victoria White
The three-year collaboration will focus on mechanistic approaches for the identification of genes or signalling pathways that modify neurodegenerative disease processes affecting neuronal health...
12 October 2015 | By Victoria White
The Dementia Consortium is a £3.5m drug discovery collaboration between Alzheimer’s Research UK, MRC Technology, Eisai, Lilly and now Astex...
9 October 2015 | By Victoria White
Researchers reported that treatment with IFNβ-gene therapy successfully prevented neuronal death and disease effects in an experimental model of the disease...
5 October 2015 | By Victoria White
Rats given RGFP966 were more attuned to what they were hearing and were able to retain and remember more information...
16 September 2015 | By Victoria White
A team at the International Centre for Genetic Engineering and Biotechnology (ICGEB) will join forces with MRC Technology to take on the project...
28 July 2015 | By Victoria White
UMG and MRC Technology are to collaborate to develop a novel therapy for neurodegenerative diseases based on antibody targeting amyloid beta peptides 4-x...
21 July 2015 | By Victoria White
Examining post-mortem tissue from the brains of people with Alzheimer's disease, researchers identified iron-containing microglia in the hippocampus...
20 July 2015 | By Victoria White
Certain patients with type 2 diabetes may have specific genetic risk factors that put them at higher risk for developing Alzheimer’s disease...
13 July 2015 | By Victoria White
Probiodrug is to provide funding to further investigate the potential of pGlu-Abeta antibodies for passive vaccination against Alzheimer's disease...
24 June 2015 | By Victoria White
Scientists have identified a single blood protein that may indicate the development a disorder associated with an increased risk of Alzheimer's disease...
